Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
LSE:FAB
Price:
3.4 GBX
Market Closed
Updated:
May 14, 2024
Fusion Antibodies PLC
Accumulated Depreciation
|
Fusion Antibodies PLC
Accumulated Depreciation Peer Comparison
Comparables:
ONT
O
ORPH
DXRX
ERGO
HVO
Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accumulated Depreciation | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Fusion Antibodies PLC
LSE:FAB
|
Accumulated Depreciation
-£3.3m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Accumulated Depreciation
-£4.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Diaceutics PLC
LSE:DXRX
|
Accumulated Depreciation
-£598k
|
CAGR 3-Years
-69%
|
CAGR 5-Years
-64%
|
CAGR 10-Years
N/A
|
|
|
Ergomed PLC
LSE:ERGO
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Fusion Antibodies PLC's Accumulated Depreciation?
Accumulated Depreciation
-3.3m
GBP
-3.3m
GBP
Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Accumulated Depreciation amounts to -3.3m GBP.
What is Fusion Antibodies PLC's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 3Y
-19%
-19%
Over the last year, the Accumulated Depreciation growth was -6%. The average annual Accumulated Depreciation growth rates for Fusion Antibodies PLC have been -19% over the past three years .
You don't have any saved screeners yet
